New imaging technique to detect and understand prostate cancer in men with metal implants

Who could benefit from this research

What this research studies

This research focuses on improving the detection and characterization of prostate cancer using a novel 3D diffusion-weighted imaging (DWI) technique, specifically designed for men who have pelvic metal implants. The study aims to address the challenges posed by these implants, which can distort MRI images and hinder accurate diagnosis. By enhancing imaging capabilities, the research seeks to provide better guidance for treatment decisions in men at high risk for prostate cancer, particularly those with rising PSA levels or undergoing active surveillance. The approach involves advanced imaging technology to ensure clearer visualization of prostate lesions, which is crucial for effective disease management.

Why it matters

Where this research is happening

• Mayo Clinic Rochester
  Rochester, United States Active

Researchers

• Principal investigator: Madhuranthakam, Ananth J — Mayo Clinic Rochester
• Study coordinator: Madhuranthakam, Ananth J

Related research

Other NIH-funded projects on the same topics.

• Cardiovascular risk planning and reduction for men with prostate cancer

  A program to better predict and reduce heart disease risk in men treated for prostate cancer, especially older patients.

  NIH research University of Pennsylvania · Philadelphia, United States · NIH-11627340

• Effects of ADT on motivation and emotion in prostate cancer patients

  This project looks at how androgen deprivation therapy may affect motivation and mood over time in men with prostate cancer.

  NIH research VA Connecticut Healthcare System · West Haven, United States · NIH-11615971

• Causal Protein Markers to Understand and Predict Prostate Cancer Risk in Africans and Europeans

  A cancer research project looking at proteins linked to prostate cancer to better understand why it happens and how risk differs between African and European populations.

  NIH research Lsu Health Sciences Center · New Orleans, United States · NIH-11611654

• Ethical multimodal AI platform to improve prostate cancer detection with ultrasound

  A patient-friendly AI system uses ultrasound and MRI information to help doctors better find prostate cancer, aiming to improve accuracy and access.

  NIH research Stanford University · Stanford, United States · NIH-11596787

• Characterizing epigenetic targets in prostate cancer to help AR-driven cancer

  A research project at MD Anderson aims to understand how epigenetic factors shape androgen receptor signaling in prostate cancer to find new ways to treat resistant forms of the disease.

  NIH research University of Tx Md Anderson Can Ctr · Houston, United States · NIH-11573812

• AR and RNA-binding in prostate cancer resistance

  A cancer research grant exploring how the androgen receptor’s interaction with RNA may drive treatment resistance in prostate cancer, with potential to guide new therapies.

  NIH research Wayne State University · Detroit, United States · NIH-11541342

About this research

1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.